Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients
Clinical trial NCT01249456 · COMPLETED
Trial details
- NCT number
- NCT01249456
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-05-01
- Primary completion
- 2015-04-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.